Rabeprazole Clinical Trials

• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
  ClinicalTrials.gov Identifier: NCT00216450 - Active, not recruiting
  Bacterial Infections; Helicobacter Infections
  
• Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
  ClinicalTrials.gov Identifier: NCT00132496 - Active, not recruiting
  Gastroesophageal Reflux Disease GERD
  
• Safety of Rabeprazole in Patients Under Multiple Treatments.
  ClinicalTrials.gov Identifier: NCT00511745 - Active, not recruiting
  Gastric Ulcer; Gastroesophageal Reflux
  
• E3810-A001-313: Efficacy and Safety of 10 Mg Rabeprazole for Treating Heartburn in Frequent Sufferers
  ClinicalTrials.gov Identifier: NCT00236184 - Active, not recruiting
  Heartburn
  
• E3810-A001-312: Efficacy and Safety of 10 Mg Rabeprazole for Treating Heartburn in Frequent Sufferers
  ClinicalTrials.gov Identifier: NCT00236197 - Active, not recruiting
  Heartburn
  
• Rabeprazole Protection of Aspirin Induced Gastric Damage.
  ClinicalTrials.gov Identifier: NCT00220857 - Recruiting
  Normal Subjects
  
• A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
  ClinicalTrials.gov Identifier: NCT00216489 - Active, not recruiting
  Heartburn; Gastroesophageal Reflux
  
• Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.
  ClinicalTrials.gov Identifier: NCT00553449 - Active, not recruiting
  Heartburn; Gastroesophageal Reflux
  
• Rabeprazole 20 mg Maintenance Intermittent Therapy Following Acute Treatment in Patients With Symptomatic Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00165841 - Active, not recruiting
  Gastroesophageal Reflux Disease
  
• Prospective Double-Blinded Randomized Controlled Trial of 12-Weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
  ClinicalTrials.gov Identifier: NCT00517114 - Recruiting
  Gastroesophageal Reflux; Laryngitis
  
• A Double-Blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
  ClinicalTrials.gov Identifier: NCT00125736 - Recruiting
  Stomach Ulcer
  
• A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomperazole 40m
  ClinicalTrials.gov Identifier: NCT00464308 - Recruiting
  Gastro-Oesophageal Reflux
  
• Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI.
  ClinicalTrials.gov Identifier: NCT00251732 - Not yet recruiting
  GERD; Acid Reflux Disease; Gastroesophageal Reflux Disease
  
• Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
  ClinicalTrials.gov Identifier: NCT00222170 - Completed
  Esophageal Reflux
  
• Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
  ClinicalTrials.gov Identifier: NCT00214552 - Completed
  Asthma; Gastroesophageal Reflux Disease
  
• A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole
  ClinicalTrials.gov Identifier: NCT00378287 - Completed
  GERD
  
• A Study of Efficacy and Safety of "on-Demand" Maintenance Therapy With Rabeprazole in Patients With Non-Erosive Reflux Disease (NERD)
  ClinicalTrials.gov Identifier: NCT00236392 - Completed
  Heartburn; Gastroesophageal Reflux
  
• A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn
  ClinicalTrials.gov Identifier: NCT00237367 - Completed
  Gastroesophageal Reflux